Cimon Medical

Cimon Medical is a pioneering biotechnology and manufacturing startup based in Norway, founded in 2020. The company's slogan, "Using ultrasound technology to uncover the hidden world of blood flow," encapsulates its innovative approach. Cimon Medical aims to revolutionize blood circulation monitoring technology by making it standard in all critical care hospitals. By leveraging ultrasound technology, they intend to prevent life-threatening trends and events during critical care and surgery. The company's roots can be traced back to the esteemed ultrasound departments of NTNU (The Norwegian University of Science and Technology) and St. Olav’s Hospital in Trondheim, Norway. Cimon Medical has recently secured a significant kr60.00M Series A investment at 11 December 2020. The investors involved in this milestone funding round include Investinor, Farvatn Venture, CoFounder, and ProVenture. Cimon Medical's vision, combined with its strong foundation and substantial recent investment, positions the company as an intriguing prospect for potential investors in the biotechnology and healthcare sectors. As the demand for advanced medical technologies continues to grow, Cimon Medical's focus on improving patient outcomes through enhanced blood flow monitoring could potentially have a substantial impact in critical care settings globally. This, coupled with the impressive backing from prominent investors, makes Cimon Medical a prospective venture for consideration within the startup investment landscape.